Cue Biopharma Inc. (NASDAQ: CUE) Stock Information | RedChip

Cue Biopharma Inc. (NASDAQ: CUE)


$1.0100
N/A ( 0% ) 106.9K

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune disease with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103 and others.

Market Data


Open


$1.0100

Previous close


$1.0100

Volume


106.9K

Market cap


$64.08M

Day range


$0.9850 - $1.0350

52 week range


$0.4500 - $3.2000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Sep 05, 2024
8-k 8K-related 11 Sep 03, 2024
pre Proxies and info statements 6 Aug 28, 2024
8-k 8K-related 11 Aug 16, 2024
10-q Quarterly Reports 77 Aug 14, 2024
8-k 8K-related 13 Jul 25, 2024
8-k 8K-related 11 Jun 07, 2024
3 Insider transactions 2 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024
4 Insider transactions 1 Jun 07, 2024

Latest News